BEN-MAIMON CAROLE — SEC insider filings
SEC reporting owner CIK 1529611. 13 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2020-09-30 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 54,796 shares, $168,478 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 31,746 shares @ $3.15 ($100,000) in Larimar Therapeutics, Inc., filed 2022-09-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | President and CEO, Director | 11 | 3 legs · 54,796 sh · $168,478 | — | 12 |
| Teligent, Inc. (TLGT) | Director | 2 | — | — | 2 |
Insider filings — BEN-MAIMON CAROLE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 18,050 @ $2.77 | EDGAR |
| 2026-01-27 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 100,100 @ $0 · Grant/award (A): 600,600 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 91,000 @ $0 · Grant/award (A): 546,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 66,125 @ $0 · Grant/award (A): 396,750 (derivative) @ $0 | EDGAR |
| 2023-05-18 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 5,000 @ $3.71 | EDGAR |
| 2023-02-02 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 205,000 @ $0 · Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2022-09-19 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 31,746 @ $3.15 | EDGAR |
| 2022-05-12 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 182,000 (derivative) @ $0 | EDGAR |
| 2021-07-22 | 4 | Teligent, Inc. (TLGT) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-01-21 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 106,700 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Teligent, Inc. (TLGT) | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2020-09-30 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 411,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1529611 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs